Dr Reddy's Announces Collaboration with SkyePharma

Dr Reddys Laboratories Ltd on February 08, 2008 has announced that it has entered into an agreement with SkyePharma PLC (LSE: SKP) to undertake a feasibility study of a product utilizing two of SkyePharma's proprietary drug delivery systems. The costs of this study will be paid by Dr Reddy's. SkyePharma will also receive an upfront payment. If the feasibility study is successful, full development activities will begin later this year.